Author: kknights@illinois.edu
Congratulations to Rachel Schaaf for winning a predoctoral fellowship from the ACS Division of Medicinal Chemistry! and More here!
Complete breast tumor regressions induced by a single dose of ErSO-TFPy in mouse models, see In The Pipeline highlight
Congratulations to postdoc Dr. Diana Ranoa on beginning her new position as an Assistant Professor in the Department of Biochemistry at UIUC!
Listen to Let’s Talk Micro podcast on fabimycin and another on lolimicin.
Listen to Let’s Talk Micro podcast on fabimycin and another on Lolamicin.
Former Postdoc Prof. Sarah Tasker Featured in C&E News
Former Postdoc Prof. Sarah Tasker Featured in C&E News Sarah Tasker, an assistant professor of chemistry at Franklin & Marshall College, received an ACS PRF grant in 2018 with the proposal “Synthesis of Oxetanes via a Formal Formylation.”
Rebecca Ulrich awarded the 15th Irving S. Sigal Postdoctoral Fellowship
The American Chemical Society has awarded Rebecca Ulrich of the University of Illinois Urbana-Champaign the 15th Irving S. Sigal Postdoctoral Fellowship for 2024–2026. Ulrich will conduct her fellowship studies with Deborah Hung of the Broad Institute starting Sept. 1. Read more…
New antibiotic kills pathogenic bacteria, spares healthy gut microbes, see Nature paper
Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut. Read More
NEW: Rules for compound accumulation in P. aeruginosa published in Nature.
UIUC Press Release Team discovers rules for breaking into Pseudomonas Researchers report in the journal Nature that they have found a way to get antibacterial drugs through the nearly impenetrable outer membrane of Pseudomonas aeruginosa, a bacterium that – once it infects a person – is notoriously difficult to treat. Read more
NEW: A compound from the Hergenrother/Shapiro collaboration has been licensed and is advancing toward treatment of breast cancer.
Unprecedented Compound Takes a Step Toward Breast Cancer Clinical Trials Estrogen receptor-positive breast cancer is the most common form of breast cancer, affecting approximately 75% of breast cancer patients. In advanced and metastatic form, it is lethal, claiming the lives of nearly 350,000 individuals annually. Presently, no drug is able to eradicate these advanced tumors. […]